Literature DB >> 21042758

Adenovirus-mediated SOCS3 gene transfer inhibits the growth and enhances the radiosensitivity of human non-small cell lung cancer cells.

Yu-Ching Lin1, Chin-Kuo Lin, Ying-Huang Tsai, Hsu-Huei Weng, Ya-Chin Li, Liang You, Jan-Kan Chen, David M Jablons, Cheng-Ta Yang.   

Abstract

The Janus kinase-signal transducers and activators of transcription (JAK-STAT) pathway is one of the most important components of cytokine signaling cascades. JAK-STAT signaling pathway modulates various fundamental biological processes and cancer pathogenesis. JAK-STAT is controlled by negative regulators that include suppressors of cytokine signaling (SOCS) proteins. Failure of feedback suppression by SOCS proteins may result in activated JAK-STAT signaling. Methylation-mediated silencing of SOCS3 has been reported in non-small lung cancer (NSCLC) and other human cancers. In this study, we restored SOCS3 expression using adenovirus-mediated gene transfer in NSCLC cells. Infection with a SOCS3-expressing vector inhibited the growth of lung cancer cells, with or without SOCS3 expression, at 2-3 days after infection. The growth inhibition of lung cancer cells was associated with suppressing entry into the S-phase. Restoration of SOCS3 expression induced apoptosis of NSCLC cells that did not express SOCS3. In addition, overexpression of SOCS3 by adenoviral transfer enhanced the radiosensitivity of treated NSCLC cells. In conclusion, our findings may provide insights into the development of applications of SOCS3 gene therapy for lung cancer and, possibly, other human cancers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21042758     DOI: 10.3892/or_00001024

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  15 in total

1.  Alveolar macrophage secretion of vesicular SOCS3 represents a platform for lung cancer therapeutics.

Authors:  Jennifer M Speth; Loka R Penke; Joseph D Bazzill; Kyung Soo Park; Rafael Gil de Rubio; Daniel J Schneider; Hideyasu Ouchi; James J Moon; Venkateshwar G Keshamouni; Rachel L Zemans; Vibha N Lama; Douglas A Arenberg; Marc Peters-Golden
Journal:  JCI Insight       Date:  2019-10-17

2.  SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer.

Authors:  Jun Wang; Hong Zhou; Yong Han; Xiulan Liu; Min Wang; Xin Wang; Guoxiao Yin; Xu Li; Ming Xiang
Journal:  J Mol Med (Berl)       Date:  2014-07-05       Impact factor: 4.599

Review 3.  SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?

Authors:  R Mahony; S Ahmed; C Diskin; N J Stevenson
Journal:  Cell Mol Life Sci       Date:  2016-05-02       Impact factor: 9.261

4.  Lymph node metastasis is mediated by suppressor of cytokine signaling-3 in gastric cancer.

Authors:  Jingyu Deng; Xuguang Jiao; Honggen Liu; Liangliang Wu; Rupeng Zhang; Baogui Wang; Yi Pan; Xishan Hao; Han Liang
Journal:  Tumour Biol       Date:  2013-07-04

5.  Chimeric Peptidomimetics of SOCS 3 Able to Interact with JAK2 as Anti-inflammatory Compounds.

Authors:  Sara La Manna; Laura Lopez-Sanz; Flavia Anna Mercurio; Sara Fortuna; Marilisa Leone; Carmen Gomez-Guerrero; Daniela Marasco
Journal:  ACS Med Chem Lett       Date:  2020-03-19       Impact factor: 4.345

6.  MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis.

Authors:  Yan Yang; Lili Ding; Qun Hu; Jia Xia; Junjie Sun; Xudong Wang; Hua Xiong; Deepak Gurbani; Lianbo Li; Yan Liu; Aiguo Liu
Journal:  Mol Cancer       Date:  2017-08-22       Impact factor: 27.401

Review 7.  SOCS, inflammation, and cancer.

Authors:  Kyoko Inagaki-Ohara; Taisuke Kondo; Minako Ito; Akihiko Yoshimura
Journal:  JAKSTAT       Date:  2013-08-15

8.  Interleukin-10-regulated tumour tolerance in non-small cell lung cancer.

Authors:  Julius Malte Vahl; Juliane Friedrich; Susanne Mittler; Sonja Trump; Lisanne Heim; Katerina Kachler; Liubov Balabko; Nicole Fuhrich; Carol-Immanuel Geppert; Denis Iulian Trufa; Nina Sopel; Ralf Rieker; Horia Sirbu; Susetta Finotto
Journal:  Br J Cancer       Date:  2017-10-10       Impact factor: 7.640

Review 9.  [The Role of SOCS in the Development of Tumors].

Authors:  Chunlai Liu; Hongyu Liu; Jun Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-09-20

10.  [Methylation Status of the SOCS3 Gene Promoter in H2228 Cells and 
EML4-ALK-positive Lung Cancer Tissues].

Authors:  Chunlai Liu; Yongwen Li; Yunlong Dong; Hongbing Zhang; Ying Li; Hongyu Liu; Jun Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.